[ORGANIZATION]
Avidity Partners Management LP
Featured in 3 tracked stories · first seen
Situations
Tempus AI earnings, Personalis acquisition, and market shift
5 clusters · 9 sources · last updated
Latest: Tempus AI shares surge following Merck and Moderna cancer vaccine trial results
In early August 2026, Tempus AI reported a 22% year-over-year increase in second-quarter revenue to $382.5 million, driven by growth in both diagnostics and data-applications segments. The company announced FDA approval